| Financial Year |
March 31 2023 |
| Monetary Funds |
8,208,315,122.67 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,662,889,940.34 |
| Accounts Receivable |
3,033,457,388.97 |
| Advances to Suppliers |
1,535,785,680.42 |
| Other Receivables |
1,460,162,270.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,309,200.73 |
| Dividend Receivable |
-- |
| Inventories |
6,002,579,469.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
249,379,025.61 |
| Total Current Assets |
26,040,688,752.93 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
39,516,548.28 |
| Long-term Equity Investment |
4,990,869,964.12 |
| Investment Properties |
8,176,784.95 |
| Fixed Assetes |
19,205,445,324.27 |
| Under-construction Projects |
2,677,856,402.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,653,003,978.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
207,700.11 |
| Deferred Income Tax Assets |
457,474,491.63 |
| Other Non-Current Assets |
377,230,026.49 |
| Sub-Total of Non-Current Assets |
31,224,970,341.73 |
| Total Assets |
57,265,659,094.66 |
| Short-Term Loans |
4,775,224,278.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,018,438,109.13 |
| Accounts Payable |
6,595,412,215.24 |
| Accounts Received In Advance |
439,256.75 |
| Employee Compensation Payable |
204,627,022.65 |
| Taxes Payable |
340,555,123.69 |
| Interest Payable |
108,216,270.87 |
| Dividend Payable |
61,085,265.80 |
| Other payables |
1,416,636,883.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
129,475,393.63 |
| Other Current Liabilities |
314,179,817.65 |
| Sub-Total of Current Liabilities |
17,712,223,634.55 |
| Long-term Loans |
6,819,591,168.34 |
| Bonds Payable |
3,929,113,393.76 |
| Long-Term Accounts Payable |
10,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
123,267,684.74 |
| Deferred Income Tax Liabilities |
271,605,723.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,533,679,589.93 |
| Total Liabilities |
29,245,903,224.48 |
| Paid-In Capital(Or Share Stock) |
3,990,058,776.00 |
| Capital Surplus |
8,510,312,117.17 |
| Surplus Reserve |
1,920,982,495.68 |
| LESS:Treasury Stock |
112,198,810.99 |
| Undistributed Profits |
11,693,898,308.85 |
| Minority Stockholder's Interest |
2,968,117,438.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
25,051,638,432.02 |
| Owner's Equity（Stockholder's Equity） |
28,019,755,870.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
57,265,659,094.66 |
